SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

3 ▪ Pernix Therapeutics Holdings, Inc. has engaged Guggenheim Securities as its financial advisor and investment banker to assist in the evaluation of various strategic and financial alternatives, including a potential sale of the Company. ▪ All inquiries regarding the Company, the Process and the Potential Transaction, as well as any requests for additional information and access to the Company’s management, should only be directed to one of the representatives of Guggenheim Securities listed below. Unless otherwise approved in advance by Guggenheim Securities, prospective acquirors should under no circumstances communicate directly with the Company or its management, employees, customers, suppliers and other constituencies. Guggenheim Securities, LLC 330 Madison Avenue New York, NY 10017 (212) 518 - 9200 Guggenheim Securities, LLC Healthcare Liability Management Ken Springer Senior Managing Director (212) 901 - 9322 ken.springer @ guggenheimpartners.com Punit Mehta Senior Managing Director (212) 518 - 9187 punit.mehta @ guggenheimpartners.com Stuart Erickson Senior Managing Director (212) 518 - 9005 stuart.erickson @ guggenheimpartners.com Peter Schwaikert Managing Director (212) 381 - 4134 peter.schwaikert @ guggenheimpartners.com Zachary Yost Associate (212) 518 - 9599 zachary.yost@ guggenheimpartners.com Transaction Summary and Contact Information